|
Jan 21, 2026 |
Leonard Damien
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 1, 2025 |
Dec 3, 2025 |
Pinetree Capital Ltd.
|
10% Owner |
Buy |
92.5
|
+130,000
|
3.19%
|
✗
|
$2.9M |
| Nov 17, 2025 |
Nov 20, 2025 |
Pinetree Capital Ltd.
|
10% Owner |
Buy |
85.0
|
+37,847
|
1.04%
|
✗
|
$777.2K |
| Nov 17, 2025 |
Nov 19, 2025 |
Pinetree Capital Ltd.
|
10% Owner |
Buy |
75.0
|
+32,847
|
0.90%
|
✗
|
$674.6K |
| Nov 11, 2025 |
Nov 18, 2025 |
Daughton Michael
|
Chief Business Officer |
Buy |
97.5
|
+50,000
|
667.38%
|
✗
|
$999.2K |
| Nov 12, 2025 |
Nov 14, 2025 |
Pinetree Capital Ltd.
|
10% Owner |
Buy |
90.0
|
+48,903
|
3.16%
|
✗
|
$990.5K |
| Oct 15, 2025 |
Oct 15, 2025 |
Daughton Michael
|
Chief Business Officer |
Neutral |
90.0
|
+7,492
|
100.00%
|
✗
|
- |
|
Oct 6, 2025 |
Daughton Michael
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2025 |
Aug 15, 2025 |
Harse David
|
General Manager Patient Care |
Sell |
26.3
|
-1,744
|
-8.81%
|
✗
|
$47.8K |
| May 20, 2025 |
Jul 28, 2025 |
MacIntyre Vita
|
Controller |
Sell |
27.5
|
-335
|
-13.81%
|
✗
|
$8.4K |
| Jul 1, 2024 |
Jul 3, 2025 |
Fowler Christopher L
|
CEO |
Sell |
42.5
|
-3,786
|
-2.89%
|
✗
|
$69.4K |
| May 21, 2025 |
May 23, 2025 |
L6 Holdings Inc.
|
10% Owner |
Buy |
87.5
|
+70,000
|
1.50%
|
✗
|
$1.7M |
| May 21, 2025 |
May 23, 2025 |
L6 Holdings Inc.
|
10% Owner |
Buy |
87.5
|
+80,000
|
1.72%
|
✗
|
$1.9M |
| May 16, 2025 |
May 20, 2025 |
Fowler Christopher L
|
CEO |
Sell |
22.5
|
-6,000
|
-4.38%
|
✗
|
$150.3K |
| Mar 27, 2025 |
Mar 31, 2025 |
MacIntyre Vita
|
Controller |
Sell |
47.5
|
-188
|
-7.19%
|
✗
|
$5.4K |
| Mar 13, 2025 |
Mar 26, 2025 |
Wilson Merideth
|
Financial Health GM |
Neutral |
90.0
|
+7,440
|
100.00%
|
✗
|
- |
| Mar 19, 2025 |
Mar 21, 2025 |
L6 Holdings Inc.
|
10% Owner |
Buy |
87.5
|
+96,607
|
2.15%
|
✗
|
$2.6M |
| Mar 17, 2025 |
Mar 18, 2025 |
Bassi Vinay
|
CFO |
Sell |
42.5
|
-3,965
|
-8.35%
|
✗
|
$111.4K |
| Mar 17, 2025 |
Mar 18, 2025 |
Severance Dawn M
|
Chief Sales Officer |
Sell |
46.3
|
-1,122
|
-3.54%
|
✗
|
$31.5K |
| Mar 17, 2025 |
Mar 18, 2025 |
Plessner Kevin
|
General Counsel |
Sell |
46.3
|
-798
|
-5.60%
|
✗
|
$22.4K |
| Mar 17, 2025 |
Mar 18, 2025 |
Harse David
|
General Manager Patient Care |
Sell |
46.3
|
-1,098
|
-5.25%
|
✗
|
$30.9K |
| Mar 17, 2025 |
Mar 18, 2025 |
Fowler Christopher L
|
CEO |
Sell |
42.5
|
-5,849
|
-4.09%
|
✗
|
$164.4K |
| Mar 14, 2025 |
Mar 17, 2025 |
Fowler Christopher L
|
CEO |
Sell |
22.5
|
-5,100
|
-3.44%
|
✗
|
$137.8K |
| Mar 13, 2025 |
Mar 14, 2025 |
Anquillare Mark V
|
Director |
Neutral |
90.0
|
+4,376
|
25.47%
|
✗
|
- |
| Mar 13, 2025 |
Mar 14, 2025 |
Benjamin Regina M.
|
Director |
Neutral |
90.0
|
+4,376
|
12.75%
|
✗
|
- |
| Mar 13, 2025 |
Mar 14, 2025 |
Canada Jerry G Jr.
|
Director |
Neutral |
90.0
|
+4,376
|
100.00%
|
✗
|
- |
| Mar 13, 2025 |
Mar 14, 2025 |
DYE DAVID A
|
Director |
Neutral |
82.5
|
+4,376
|
3.10%
|
✗
|
- |
| Mar 13, 2025 |
Mar 14, 2025 |
HJELM CHRISTOPHER T
|
Director |
Neutral |
90.0
|
+4,376
|
16.08%
|
✗
|
- |
| Mar 13, 2025 |
Mar 14, 2025 |
O'Keefe Amy K
|
Director |
Neutral |
90.0
|
+4,376
|
137.39%
|
✗
|
- |
| Mar 13, 2025 |
Mar 14, 2025 |
TOBIN GLENN
|
Director |
Neutral |
85.0
|
+4,376
|
9.45%
|
✗
|
- |
| Mar 13, 2025 |
Mar 14, 2025 |
Bassi Vinay
|
CFO |
Neutral |
90.0
|
+14,588
|
44.34%
|
✗
|
- |
| Mar 13, 2025 |
Mar 14, 2025 |
Fowler Christopher L
|
CEO |
Neutral |
90.0
|
+22,611
|
18.02%
|
✗
|
- |
| Mar 13, 2025 |
Mar 14, 2025 |
Harse David
|
General Manager Patient Care |
Neutral |
90.0
|
+5,835
|
38.73%
|
✗
|
- |
| Mar 13, 2025 |
Mar 14, 2025 |
MacIntyre Vita
|
Controller |
Neutral |
90.0
|
+1,044
|
66.54%
|
✗
|
- |
| Mar 13, 2025 |
Mar 14, 2025 |
Plessner Kevin
|
General Counsel |
Neutral |
90.0
|
+2,985
|
26.49%
|
✗
|
- |
| Mar 13, 2025 |
Mar 14, 2025 |
Severance Dawn M
|
Chief Sales Officer |
Neutral |
90.0
|
+5,055
|
18.96%
|
✗
|
- |
| Mar 13, 2025 |
Mar 14, 2025 |
Wilson Merideth
|
Financial Health GM |
Neutral |
90.0
|
+5,981
|
100.00%
|
✗
|
- |
| Mar 13, 2025 |
Mar 14, 2025 |
Upitis Andris
|
Director |
Neutral |
60.0
|
+4,376
|
0.39%
|
✗
|
- |
| Mar 7, 2025 |
Mar 11, 2025 |
Plessner Kevin
|
General Counsel |
Sell |
46.3
|
-517
|
-4.39%
|
✗
|
$14.6K |
| Mar 7, 2025 |
Mar 11, 2025 |
Fowler Christopher L
|
CEO |
Sell |
42.5
|
-2,883
|
-2.25%
|
✗
|
$81.6K |
| Mar 7, 2025 |
Mar 11, 2025 |
Severance Dawn M
|
Chief Sales Officer |
Sell |
46.3
|
-714
|
-2.61%
|
✗
|
$20.2K |
|
Mar 7, 2025 |
Harse David
|
General Manager Patient Care |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2024 |
Feb 27, 2025 |
MacIntyre Vita
|
Controller |
Neutral |
90.0
|
+1,569
|
100.00%
|
✗
|
- |
| Nov 14, 2023 |
Feb 27, 2025 |
Fowler Christopher L
|
CEO |
Buy |
90.0
|
+16
|
100.00%
|
✗
|
$178.6 |
| Feb 24, 2025 |
Feb 26, 2025 |
L6 Holdings Inc.
|
10% Owner |
Buy |
92.5
|
+117,609
|
2.79%
|
✗
|
$3.3M |
| Feb 19, 2025 |
Feb 21, 2025 |
Pinetree Capital Ltd.
|
10% Owner |
Buy |
92.5
|
+124,858
|
4.04%
|
✗
|
$3.5M |
|
Feb 20, 2025 |
Canada Jerry G Jr.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 20, 2025 |
Wilson Merideth
|
Financial Health GM |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 20, 2025 |
Harse David
|
General Manager Patient Care |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 19, 2025 |
Upitis Andris
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 18, 2025 |
Pinetree Capital Ltd.
|
10% Owner |
Buy |
92.5
|
+110,176
|
3.75%
|
✗
|
$3.1M |
| Nov 25, 2024 |
Nov 25, 2024 |
Anquillare Mark V
|
Director |
Buy |
91.3
|
+2,500
|
17.03%
|
✗
|
$42K |
| Oct 18, 2024 |
Oct 28, 2024 |
O'Keefe Amy K
|
Director |
Neutral |
90.0
|
+3,185
|
100.00%
|
✗
|
- |
|
Oct 28, 2024 |
O'Keefe Amy K
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 2, 2024 |
Oct 4, 2024 |
Pinetree Capital Ltd.
|
10% Owner |
Buy |
72.5
|
+19,455
|
0.69%
|
✗
|
$232.1K |
| Jun 28, 2024 |
Jul 2, 2024 |
Pinetree Capital Ltd.
|
10% Owner |
Buy |
95.0
|
+122,488
|
5.83%
|
✗
|
$1.3M |
| Jun 3, 2024 |
Jun 5, 2024 |
Pinetree Capital Ltd.
|
10% Owner |
Buy |
92.5
|
+72,568
|
7.07%
|
✗
|
$687.4K |
| May 10, 2024 |
May 14, 2024 |
Pinetree Capital Ltd.
|
10% Owner |
Buy |
72.5
|
+11,789
|
0.58%
|
✗
|
$100.6K |
|
Apr 2, 2024 |
MacIntyre Vita
|
Controller |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 21, 2024 |
Mar 25, 2024 |
L6 Holdings Inc.
|
10% Owner |
Buy |
90.0
|
+106,500
|
3.72%
|
✗
|
$998.3K |
| Mar 15, 2024 |
Mar 19, 2024 |
L6 Holdings Inc.
|
10% Owner |
Buy |
90.0
|
+88,386
|
3.32%
|
✗
|
$876.1K |
| Mar 15, 2024 |
Mar 19, 2024 |
Park Lance
|
VP Finance & Controller |
Neutral |
90.0
|
+9,970
|
323.49%
|
✗
|
- |
| Mar 15, 2024 |
Mar 19, 2024 |
Bassi Vinay
|
CFO |
Neutral |
90.0
|
+32,901
|
100.00%
|
✗
|
- |
| Mar 15, 2024 |
Mar 19, 2024 |
Cronkite Wes
|
Chief Technology & Innovation |
Neutral |
90.0
|
+20,128
|
97.76%
|
✗
|
- |
| Mar 15, 2024 |
Mar 19, 2024 |
Severance Dawn M
|
Chief Sales Officer |
Neutral |
90.0
|
+13,819
|
101.93%
|
✗
|
- |
| Mar 15, 2024 |
Mar 19, 2024 |
DYE DAVID A
|
COO |
Neutral |
90.0
|
+28,548
|
25.37%
|
✗
|
- |
| Mar 15, 2024 |
Mar 19, 2024 |
Fowler Christopher L
|
CEO |
Neutral |
90.0
|
+49,850
|
63.53%
|
✗
|
- |
| Mar 15, 2024 |
Mar 19, 2024 |
Warren Denise Wilder
|
Director |
Neutral |
90.0
|
+11,964
|
53.54%
|
✗
|
- |
| Mar 15, 2024 |
Mar 19, 2024 |
TOBIN GLENN
|
Director |
Neutral |
90.0
|
+11,964
|
34.83%
|
✗
|
- |
| Mar 15, 2024 |
Mar 19, 2024 |
Benjamin Regina M.
|
Director |
Neutral |
90.0
|
+11,964
|
53.54%
|
✗
|
- |
| Mar 15, 2024 |
Mar 19, 2024 |
Anquillare Mark V
|
Director |
Neutral |
90.0
|
+11,964
|
440.83%
|
✗
|
- |
| Mar 15, 2024 |
Mar 19, 2024 |
HJELM CHRISTOPHER T
|
Director |
Neutral |
90.0
|
+11,964
|
78.45%
|
✗
|
- |
| Mar 15, 2024 |
Mar 19, 2024 |
Plessner Kevin
|
General Counsel |
Neutral |
90.0
|
+7,238
|
159.11%
|
✗
|
- |
| Mar 12, 2024 |
Mar 14, 2024 |
L6 Holdings Inc.
|
10% Owner |
Buy |
100.0
|
+328,814
|
15.75%
|
✗
|
$3.1M |
|
Mar 12, 2024 |
Pinetree Capital Ltd.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 7, 2024 |
Mar 11, 2024 |
Cronkite Wes
|
Chief Technology & Innovation |
Sell |
46.3
|
-1,456
|
-6.60%
|
✗
|
$11.7K |
| Mar 7, 2024 |
Mar 11, 2024 |
DYE DAVID A
|
COO |
Sell |
46.3
|
-3,019
|
-2.61%
|
✗
|
$25.2K |
| Mar 7, 2024 |
Mar 11, 2024 |
Plessner Kevin
|
General Counsel |
Sell |
47.5
|
-734
|
-13.89%
|
✗
|
$6.1K |
| Mar 7, 2024 |
Mar 11, 2024 |
Severance Dawn M
|
SVP of TruBridge, Sales |
Sell |
46.3
|
-1,308
|
-8.80%
|
✗
|
$11K |
| Mar 7, 2024 |
Mar 11, 2024 |
Park Lance
|
VP Finance & Controller |
Sell |
47.5
|
-339
|
-9.91%
|
✗
|
$2.7K |
| Mar 7, 2024 |
Mar 11, 2024 |
Fowler Christopher L
|
CEO |
Sell |
46.3
|
-3,733
|
-4.54%
|
✗
|
$30.9K |
| Mar 7, 2024 |
Mar 8, 2024 |
TOBIN GLENN
|
Director |
Buy |
95.0
|
+10,500
|
44.03%
|
✗
|
$84.4K |
|
Jan 12, 2024 |
Bassi Vinay
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 28, 2023 |
Jul 31, 2023 |
Anquillare Mark V
|
Director |
Neutral |
90.0
|
+2,714
|
100.00%
|
✗
|
- |
|
Jul 31, 2023 |
Anquillare Mark V
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 3, 2023 |
Jul 5, 2023 |
Fowler Christopher L
|
CEO |
Sell |
46.3
|
-1,507
|
-1.80%
|
✗
|
$38.1K |
| May 3, 2023 |
May 4, 2023 |
Cronkite Wes
|
Chief Technology & Innovation |
Neutral |
47.5
|
-1,265
|
-5.43%
|
✗
|
- |
|
Mar 20, 2023 |
Park Lance
|
VP Finance & Controller |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 7, 2023 |
Mar 17, 2023 |
Plessner Kevin
|
General Counsel |
Sell |
91.3
|
+2,070
|
64.43%
|
✗
|
$12.3K |
|
Mar 17, 2023 |
Plessner Kevin
|
General Counsel |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 7, 2023 |
Mar 17, 2023 |
Cronkite Wes
|
Chief Technology & Innovation |
Neutral |
47.5
|
-658
|
-2.75%
|
✗
|
- |
| Mar 7, 2023 |
Mar 13, 2023 |
Cronkite Wes
|
Chief Technology & Innovation |
Neutral |
90.0
|
+6,906
|
40.48%
|
✗
|
- |
|
Mar 13, 2023 |
Cronkite Wes
|
Chief Technology & Innovation |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 2, 2022 |
Mar 13, 2023 |
DYE DAVID A
|
COO |
Neutral |
27.5
|
-3,532
|
-2.97%
|
✗
|
- |
| Mar 7, 2023 |
Mar 9, 2023 |
Warren Denise Wilder
|
Director |
Neutral |
90.0
|
+4,105
|
22.50%
|
✗
|
- |
| Mar 7, 2023 |
Mar 9, 2023 |
HUFFMAN CHARLES P
|
Director |
Neutral |
90.0
|
+4,105
|
14.28%
|
✗
|
- |
| Mar 7, 2023 |
Mar 9, 2023 |
Benjamin Regina M.
|
Director |
Neutral |
90.0
|
+4,105
|
22.50%
|
✗
|
- |
| Mar 7, 2023 |
Mar 9, 2023 |
HJELM CHRISTOPHER T
|
Director |
Neutral |
90.0
|
+4,105
|
36.83%
|
✗
|
- |
| Mar 7, 2023 |
Mar 9, 2023 |
TOBIN GLENN
|
Director |
Neutral |
90.0
|
+4,105
|
20.79%
|
✗
|
- |
| Mar 8, 2023 |
Mar 9, 2023 |
Chambless Matt J
|
CFO |
Sell |
46.3
|
-759
|
-1.80%
|
✗
|
$22.8K |